BioVaxys Technology Corp.
BVAXF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,965 | $8,710 | $17,793 | $16,344 |
| - Cash | $4 | $4 | $157 | $212 |
| + Debt | $134 | $134 | $68 | $68 |
| Enterprise Value | $9,094 | $8,839 | $17,703 | $16,200 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$1,290 | -$1,206 | -$1,499 |
| % Margin | – | – | – | – |
| Net Income | -$910 | -$1,317 | -$1,070 | -$2,744 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.031 | -0.046 | -0.041 | -0.125 |
| % Growth | 32.2% | -12.2% | 67.2% | – |
| Operating Cash Flow | -$1,057 | -$8 | -$893 | -$1,015 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,057 | -$1,065 | -$893 | -$1,015 |